Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenomics and Genomics of Clozapine Pharmacotherapy
NL-OMON42072Withdrawn
- Sponsor
- University Medical Center Utrecht
- Start
- Feb 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of clozapine in schizophrenia and schizoaffective disorder (4 arms), sponsored by University Medical Center Utrecht. Primary endpoints: Primary genetic architecture endpoint and Primary polygenic risk score endpoint. Planned start Feb 2015; status: withdrawn.
02
Drugs
clozapine
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NL-OMON42072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON42072.